immunotherapy

January 25, 2016January 25, 2016

Immunotherapy for Lymphomas Related to EBV Entering Clinical Trial in Canada

News

Health Canada recently approved a Phase I clinical trial of adoptive cellular immunotherapy specific to Epstein-Barr virus (EBV) aimed at treating EBV-associated lymphomas. The technique is an adaptation of methods initially ... Read more

January 7, 2016January 7, 2016

2 Lymphoma Studies Using CAR T-cell Therapy Report ‘Tremendously Exciting’ Results

News

Presentations at the recent ASH annual meeting reporting novel results from small-scale clinical trials using CAR T-cell technology to treat lymphoma patients were reviewed in very enthusiastic terms by Dr. Marcela Maus, from the Massachusetts General Hospital Cancer Center, ... Read more

December 9, 2015May 13, 2016

Non-Hodgkin Lymphoma Study of Novartis’ T-cell Therapy Shows Early Efficacy

News

Novartis has released findings from a Phase 2a study evaluating the safety and efficacy of its novel chimeric antigen receptor T-cell (CART) immunotherapy CTL019 in two types of relapsed or refractory non-Hodgkin Lymphoma. The data was presented ... Read more

October 5, 2015October 5, 2015

Specific Biomarkers Can Predict How Certain Lymphoma Patients Respond to Treatment

News

University of Queensland researchers have recently discovered an immunological biomarker in patients with a specific type of non-Hodgkin’s lymphoma that can be used for early assessment of a patient’s response ... Read more

July 10, 2015July 10, 2015

Transfer of Immune Cells May Treat B cell Lymphoma

News

In a new study entitled “Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma” a team of researchers at the Helmholtz Zentrum München, ... Read more